BG105997A - Метод за контролиране увеличаването на теглото при прием на терапевтични средства - Google Patents

Метод за контролиране увеличаването на теглото при прием на терапевтични средства

Info

Publication number
BG105997A
BG105997A BG105997A BG10599701A BG105997A BG 105997 A BG105997 A BG 105997A BG 105997 A BG105997 A BG 105997A BG 10599701 A BG10599701 A BG 10599701A BG 105997 A BG105997 A BG 105997A
Authority
BG
Bulgaria
Prior art keywords
weight gain
gain associated
therapeutic drugs
controlling weight
certain
Prior art date
Application number
BG105997A
Other languages
English (en)
Inventor
Carl Mendel
Timothy SEATON
Steve Weinstein
Original Assignee
Knoll Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Gmbh filed Critical Knoll Gmbh
Publication of BG105997A publication Critical patent/BG105997A/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Изобретението се отнася до съединение или негови фармацевтично приемливи соли с формула@@в която R1и R2 са независимо един от друг Н или метил, например N,N-диметил-1- [1-(4-хлорофенил) циклобутил]-3-метилбутиламин хидрохлорид, евентуално под формата на неговия монохидрат. По метода се контролира увеличаването на теглото, свързано с прием на лекарствени средства, включващи трициклични антидепресанти, литий, сулфонилуреи, бета-адренергични блокери, някои стероидни противозачатъчни средства, кортикостероиди, инсулин, ципрохептадин, натриев валпроат, невролептици, фенотиазин или пизтифен.
BG105997A 1999-03-19 2001-10-10 Метод за контролиране увеличаването на теглото при прием на терапевтични средства BG105997A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12534099P 1999-03-19 1999-03-19
PCT/US2000/007130 WO2000056313A1 (en) 1999-03-19 2000-03-17 Method of controlling weight gain associated with therapeutic drugs

Publications (1)

Publication Number Publication Date
BG105997A true BG105997A (bg) 2002-06-28

Family

ID=22419292

Family Applications (1)

Application Number Title Priority Date Filing Date
BG105997A BG105997A (bg) 1999-03-19 2001-10-10 Метод за контролиране увеличаването на теглото при прием на терапевтични средства

Country Status (20)

Country Link
US (1) US6376552B1 (bg)
EP (1) EP1162965A1 (bg)
JP (1) JP2002539251A (bg)
KR (1) KR20020000784A (bg)
CN (1) CN1353603A (bg)
AU (1) AU3757800A (bg)
BG (1) BG105997A (bg)
BR (1) BR0009159A (bg)
CA (1) CA2367021A1 (bg)
CZ (1) CZ291864B6 (bg)
HU (1) HUP0200393A2 (bg)
IL (1) IL145241A0 (bg)
MX (1) MXPA01009467A (bg)
NO (1) NO20014480L (bg)
NZ (1) NZ514009A (bg)
PL (1) PL350919A1 (bg)
SK (1) SK13352001A3 (bg)
TR (1) TR200102695T2 (bg)
WO (1) WO2000056313A1 (bg)
ZA (1) ZA200107692B (bg)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002019998A2 (en) * 2000-09-08 2002-03-14 Eli Lilly And Company A method of treating weight gain associated with atypical antipsychotic use
JP4278652B2 (ja) * 2002-10-05 2009-06-17 ハンミ ファーム． シーオー．， エルティーディー． 結晶性シブトラミンメタンスルホン酸塩半水和物を含む医薬組成物
US20050131074A1 (en) * 2003-08-04 2005-06-16 Beckman Kristen M. Methods for treating metabolic syndrome
US20060035827A1 (en) * 2004-06-24 2006-02-16 Green Gary M Compositions and methods for the treatment or prevention of gallbladder disease
KR20060080817A (ko) 2005-01-06 2006-07-11 씨제이 주식회사 시부트라민의 디카복실산염
KR20060080818A (ko) * 2005-01-06 2006-07-11 씨제이 주식회사 시부트라민의 술폰산염
WO2006073292A1 (en) * 2005-01-06 2006-07-13 Cj Corporation Inorganic acid salts of sibutramine
KR20060093564A (ko) * 2005-02-22 2006-08-25 종근당바이오 주식회사 무수 시부트라민 말산염 및 이의 제조 방법
KR100627687B1 (ko) * 2005-04-20 2006-09-25 주식회사 씨티씨바이오 시부트라민 유리염기 함유 조성물 및 이의 제조방법
CN101626768B (zh) * 2006-09-15 2013-08-21 雷维瓦药品公司 环烷基甲胺的合成、使用方法和组合物
KR20080046601A (ko) * 2006-11-22 2008-05-27 에스케이케미칼주식회사 보관안정성이 우수한 시부트라민 함유 포접복합체

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2675573B2 (ja) * 1988-03-31 1997-11-12 科研製薬株式会社 脳機能改善剤
IE61928B1 (en) * 1988-11-29 1994-11-30 Boots Co Plc Treatment of obesity
US5459164A (en) * 1994-02-03 1995-10-17 Boots Pharmaceuticals, Inc. Medical treatment

Also Published As

Publication number Publication date
ZA200107692B (en) 2002-12-18
TR200102695T2 (tr) 2002-01-21
AU3757800A (en) 2000-10-09
CZ20013283A3 (cs) 2002-07-17
NO20014480L (no) 2001-11-02
EP1162965A1 (en) 2001-12-19
JP2002539251A (ja) 2002-11-19
HUP0200393A2 (en) 2002-08-28
SK13352001A3 (sk) 2002-03-05
NO20014480D0 (no) 2001-09-14
BR0009159A (pt) 2001-12-26
IL145241A0 (en) 2002-06-30
KR20020000784A (ko) 2002-01-05
CA2367021A1 (en) 2000-09-28
CN1353603A (zh) 2002-06-12
PL350919A1 (en) 2003-02-10
CZ291864B6 (cs) 2003-06-18
NZ514009A (en) 2001-09-28
US6376552B1 (en) 2002-04-23
WO2000056313A1 (en) 2000-09-28
MXPA01009467A (es) 2004-03-19

Similar Documents

Publication Publication Date Title
GEP20074208B (en) Substituted amides active at the cannabinoid-1 receptor
ATE410506T1 (de) Behandlung der pompeschen krankheit
HK19395A (en) Film-coated solid dosage form of anti-migraine drug
ATE375341T1 (de) Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
NO20022014L (no) En fast oral kontrollert frigjorende doseringsform inneholdende hydrokodon
NZ527113A (en) Rapid-onset medicament for the treatment of sexual dysfunction
FI935847A0 (fi) L-DOPA-esterkompositioner
BG105997A (bg) Метод за контролиране увеличаването на теглото при прием на терапевтични средства
MXPA02001571A (es) Metodo de tratamiento para el cancer.
GB9727131D0 (en) Therapeutic agents
EP1228758A4 (en) PROHYLACTIC AND THERAPEUTIC AGENTS FOR INFLAMMABLE COLON DISEASES
BG103278A (bg) Медикаментозно лечение
GB9108629D0 (en) Heterocyclic pharmaceutical compounds,preparation and use
HK1006284A1 (en) Thiazolidine derivatives having anti-hypertensive activity and their therapeutic use
MY113062A (en) Amide derivatives and their therapeutic use
CA2438509A1 (en) Use of cyclohexenone derivatives for the manufacture of a medicament in the treatment of dysuria
BG106180A (bg) Фармацевтичен състав, съдържащ сибутрамин и орлистат
BG106209A (bg) Лекарствени средства
TW349864B (en) Use of N-(pyridinyl)-1H-indol-a-amines for the preparation of a medicament for the treatment of obsessive-compulsive disorders
RU2005102923A (ru) Средство от диабета
MY133438A (en) Morpholinobenzamide salts
MX9303422A (es) Benzodiazepinas, procedimiento para su preparacion y medicamento que las contiene.
MXPA01009468A (es) Tratamiento de hipertension pulmonar.
DE60026559D1 (de) Arzneimittel gegen essstörungen
RU2002113918A (ru) Лечение или предупреждение гипотензии и шока